Director of Regulatory Affairs

At Avalo (ahh-vah-lowe), we are 100% focused on developing treatments for immune-mediated inflammatory diseases with large unmet needs. Our strategy is to develop medicines that target the IL-1β pathway, the central driver of the inflammatory process. Position Summary Avalon Therapeutics seeks a strategic and execution-focused Director of Regulatory Affairs to provide global regulatory leadership for abdakibart (AVTX-009) as it advances into Phase 3 and beyond. Essential Duties and Responsibilities Design, lead, and implement global regulatory strategies to support the development, registration, and lifecycle management of assigned programs. Serve as the Regulatory Affairs representative on cross-functional project teams and provide proactive, strategic guidance to advance program objectives. Evaluate evolving regulatory requirements, competitive developments, and emerging scientific trends, and assess potential impacts on development strategy. Identify regulatory risks, develop mitigation plans, and communicate recommendations to project teams and senior leadership. Contribute to regulatory development plans supporting advancement throughout development to commercialization. Collaborate with senior regulatory leadership on major strategic initiatives, including FDA and global health authority meetings, registration strategy, BLA planning, and labeling activities. Lead the planning, preparation, review, and submission of regulatory documents throughout the product lifecycle. Provide hands-on leadership for a broad range of U.S. and global regulatory submissions, such as DSURs, protocol amendments, information amendments, INDs, CTAs, labeling, etc. Ensure submissions are scientifically accurate, strategically aligned, compliant, and delivered on schedule. Lead and coordinate routine regulatory submissions independently while supporting more complex registration activities under the guidance of senior regulatory leadership. Support preparation and maintenance of future NDA/BLA and ex-US marketing application activities. Serve as a key point of contact with FDA and support interactions with ex-US regulatory agencies. Lead preparation of regulatory briefing materials, meeting requests, information packages, and responses to agency inquiries. Participate in and support regulatory authority meetings, teleconferences, and written communications. Coordinate regulatory intelligence and ensure project teams remain informed of evolving agency expectations. Manage external regulatory consultants and CRO partners supporting global CTA submissions, maintenance activities, and health authority responses. Drive accountability and alignment across functions to meet aggressive development timelines. Additional Responsibilities Participate in departmental initiatives, task forces, and special projects. Support diligence activities and regulatory assessments as needed. Perform other duties as assigned. Required Education and Experience Bachelor’s degree in a scientific discipline required. Advanced degree (MS, PharmD, PhD, or equivalent) preferred. 10–15 years of Regulatory Affairs experience within the biotechnology and/or pharmaceutical industry. Minimum of 5 years of experience within a small or emerging biotechnology company preferred. Demonstrated experience supporting late-stage clinical development programs. Proven experience authoring, reviewing, and managing a broad range of regulatory submissions, including INDs, CTAs, amendments, IND Safety Reports, DSURs, annual reports, and briefing packages. Experience interacting directly with FDA and supporting ex-US regulatory activities. Experience managing CROs and external consultants supporting global regulatory submissions and agency responses. Experience supporting preparation for major regulatory milestones such as End-of-Phase 2 meetings, Phase 3 development programs, BLA preparation, and registration planning preferred. Deep understanding of global drug development and regulatory requirements for biologics. Strong knowledge of FDA regulations and familiarity with EMA and other international regulatory frameworks. Ability to thrive in a fast-paced biotechnology environment while managing multiple priorities and deadlines. Experience working in a cross-functional team. Travel Less than 5% travel. About Avalo Therapeutics Avalo Therapeutics is a clinical-stage biotechnology company dedicated to developing therapeutics targeting the IL-1β pathway for immune-mediated inflammatory diseases. Our lead asset, abdakibart, is an anti-IL-1β monoclonal antibody that recently demonstrated positive topline data in a Phase 2 trial in hidradenitis suppurativa. We also advance AVTX-010, a long-acting next-generation anti-IL-1β mAb. For more information, visit #J-18808-Ljbffr Avalo Therapeutics, Inc.